Abstract
Objectives:The European Association of Urology (EAU) Guideline Group for renal cell carcinoma (RCC) prepared this guideline to help urologists assess the evidence-based management of RCC and to incorporate the guideline recommendations into their clinical practice. Methods :The re commendations provided in the current guideline are based on a systematic literature search using MedLine, the Cochrane Central Register of Controlled Trials, and publications and review articles. Results: A Limited Number of prospective randomized studies are available with high-level evidence.Most publications concerning RCC are based on retrospective analyses, including some larger multicentre validation studies and well-designed controlled studies. Conclusions: It must be stressed that the current guideline contains information for the treatment of an individual patient according to a standardized general approach. Updated recommendations concerning diagnosis, treatment, and follow-up can improve the clinical handling of patients with RCC.
Translated title of the contribution | Renal cell carcinoma guideline |
---|---|
Original language | Spanish |
Journal | Actas Urologicas Espanolas |
Volume | 33 |
Issue number | 3 |
Pages (from-to) | 270-279 |
Number of pages | 10 |
ISSN | 0210-4806 |
DOIs | |
Publication status | Published - 2009 |
Research Areas and Centers
- Research Area: Luebeck Integrated Oncology Network (LION)